SCHEMBL4636152

SCHEMBL4636152

Cc1ccc(N(C=O)[C@@H]2CCCCN2)cc1C1CCN(Cc2ccc(Sc3ccc(Cl)cc3)cc2)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.36
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
DRD2 P14416 5/20 0.34
DRD4 P21917 4/20 0.34
DRD3 P35462 3/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ADRA1A P35348 1/20 0.34
ALDH1A1 P00352 1/20 0.33
HTR1A P08908 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
OPRM1 P35372 1/20 0.33
OPRK1 P41145 1/20 0.33
OPRL1 P41146 1/20 0.33
CXCR4 P61073 1/20 0.33
HDAC1 Q13547 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
MLNR O43193 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4616753 0.92 DRD2 (0.40) DRD2DRD4ADRA1AALDH1A1MLNR
SCHEMBL4615165 0.91 PTGIR (0.45) ACHEMEN1KMT2ADRD2DRD4
SCHEMBL4616735 0.89 DRD2 (0.33) ACHEMEN1KMT2ADRD2DRD4
SCHEMBL4617031 0.82 MEN1 (0.38) ACHEMEN1KMT2ADRD2DRD4
Hydrochloric Acid SCHEMBL4853095 0.77 DRD2 (0.45) MEN1KMT2ADRD2ADRA1AALDH1A1
Hydrochloric Acid SCHEMBL4847788 0.77 DRD2 (0.45) MEN1KMT2ADRD2ADRA1AALDH1A1
SCHEMBL4616616 0.74 MEN1 (0.45) ACHEMEN1KMT2ADRD2DRD4
SCHEMBL4616106 0.71 CXCR4 (0.37) ACHEMEN1KMT2ADRD2DRD4
SCHEMBL4617177 0.70 DRD2 (0.54) ACHEDRD2ADRA1AALDH1A1SMN1; SMN2
SCHEMBL4617067 0.70 HSP90AA1 (0.50) DRD2ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080139555-A1 Arylthiobenzylpiperidine Derivatives H. LUNDBECK A/S (DK) 2008-06-12 US disclosed
US-7329656-B2 Arylthiobenzylpiperidine derivatives H. LUNDBECK A/S (DK) 2008-02-12 US disclosed
EP-1799223-A4 ARYLTHIOBENZYLPIPERIDINE DERIVATES LUNDBECK & CO AS H (DK) 2008-01-23 EP disclosed
EP-1799223-A2 ARYLTHIOBENZYLPIPERIDINE DERIVATES H.Lundbeck A/S (DK) 2007-06-27 EP disclosed
WO-2006041635-A2 ARYLTHIOBENZYLPIPERIDINE DERIVATIVES H. LUNDBECK A/S (DK) 2006-04-20 WO disclosed
US-20060079683-A1 Arylthiobenzylpiperidine derivatives H. LUNDBECK A/S (DK) 2006-04-13 US disclosed
US-20060079523-A1 N-[3-(1-{[4-(4-fluorophenylthio)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide; melatonin-concentrating hormone (MCH1) receptor ligand; antidepressant, anxiolytic, antidiabetic agent H. LUNDBECK A/S 2006-04-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060079523-A1 N-[3-(1-{[4-(4-fluorophenylthio)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide; melatonin-concentrating hormone (MCH1) receptor ligand; antidepressant, anxiolytic, antidiabetic agent MCHR1, MTNR1A, MTNR1B ACHE 2866/4885MEN1 438/4885KMT2A 429/4885
US-20080139555-A1 Arylthiobenzylpiperidine Derivatives MCHR1, MC4R, MCHR2 ACHE 2682/4885MEN1 1496/4885KMT2A 1897/4885
US-20060079683-A1 Arylthiobenzylpiperidine derivatives MCHR1, MC4R, MCHR2 ACHE 2608/4885MEN1 1507/4885KMT2A 1970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.